Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infectious diseases and hemostasis].

L Orosz1, G Pfliegler

  • 1Debreceni Orvostudományi Egyetem, II. sz. Belgyógyászati Klinika.

Orvosi Hetilap
|March 11, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.

Journal of thrombosis and haemostasis : JTH·2016
Same author

From excitonic to photonic polariton condensate in a ZnO-based microcavity.

Physical review letters·2013
Same author

Hepatitis C virus presumably associated bilateral consecutive anterior ischemic optic neuropathy.

European journal of ophthalmology·2008
Same author

Prevalence and avidity of human herpesvirus-6 specific IgG antibodies in pregnant women in Hungary.

Acta microbiologica et immunologica Hungarica·2006
Same author

Integrative plasmid vector for constructing single-copy reporter systems to study gene regulation in Rhizobium meliloti and related species.

Plasmid·2004
Same author

Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.

Journal of thrombosis and haemostasis : JTH·2003
Same journal

[The application of artificial intelligence in healthcare: benefits, challenges, and issues of responsibility].

Orvosi hetilap·2026
Same journal

[Long-COVID syndrome and lung-specific abnormalities following COVID-19].

Orvosi hetilap·2026
Same journal

[Validation of the Vaccination Attitudes Examination (VAX) scale in Hungary].

Orvosi hetilap·2026
Same journal

Orvosi hetilap·2026
Same journal

[The Hungarian short version and psychometric properties of the Activities-specific Balance Confidence Scale for assessing fall risk].

Orvosi hetilap·2026
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
See all related articles

This study reviews major bleeding issues like thrombocytopenia and DIC in infections, exploring their immune and non-immune causes. It also covers treatment options and risks associated with blood transfusions.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Immunology

Background:

  • Infectious diseases can trigger serious hematological complications.
  • Understanding the pathogenesis of these complications is crucial for effective management.

Purpose of the Study:

  • To survey significant hemostatic complications in infectious diseases.
  • To elucidate the immune and non-immune pathogenesis of these disorders.
  • To summarize therapeutic strategies and transfusion-related infectious risks.

Main Methods:

  • Literature review of significant hemostatic complications in infectious diseases.
  • Analysis of immune and non-immune pathogenetic mechanisms.
  • Summary of current therapeutic interventions and blood product safety.

Related Experiment Videos

Main Results:

  • Identified key hemostatic complications including thrombocytopenia, disseminated intravascular coagulation (DIC), vasculitis, and thrombotic microangiopathy.
  • Detailed the immune-mediated and non-immune pathways contributing to these conditions.
  • Outlined available treatments and highlighted infectious risks of blood component therapy.

Conclusions:

  • Hemostatic complications are a significant concern in infectious diseases with complex pathogenesis.
  • Appropriate therapeutic strategies and careful consideration of transfusion risks are essential.